Trials / Completed
CompletedNCT02700659
The Cxbladder Monitoring Study
A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urothelial Carcinoma (UC)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 803 (actual)
- Sponsor
- Pacific Edge Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this trial is to determine the performance characteristics of the Cxbladder test for the detection of recurrent urothelial carcinoma (UC) in patients with a recent history of urinary tract UC, who have been treated according to standard practice and are undergoing routine investigative cystoscopy. The gold standard for determination of clinical truth is cystoscopy, plus any follow up investigations relating to the current visit.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Cxbladder | Cxbladder is a non invasive UC detection test measuring five messenger RNA (mRNA) biomarkers present at elevated levels in patients presenting with urothelial carcinoma. |
Timeline
- Start date
- 2013-02-04
- Primary completion
- 2016-09-23
- Completion
- 2016-09-23
- First posted
- 2016-03-07
- Last updated
- 2020-03-04
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02700659. Inclusion in this directory is not an endorsement.